Biovail Corporation financial news, media coverage and headlines

NEW YORK (Market Intellisearch) -- BVF options saw interesting call activity today. A total of 294 put and 1,188 call contracts were traded raising a low Put/Call volume alert. Today's traded Put ...

By Chip Brian Shares of Biovail (NYSE:BVF) traded at a new 52-week high today of $24.06. Approximately 1 million shares have traded hands today vs. average 30-day volume of 2.8 million shares ...

By Chip Brian Biovail (NYSE:BVF) traded in a range yesterday that spanned from a low of $23.14 to a high of $24.25. Yesterday, the shares gained 4.20%, which took the trading range above the 3-day ... SmarTrend Detects Potential Break Out In Shares of Biovail (BVF) - Benzinga

By Chip Brian Biovail (NYSE:BVF) traded in a range yesterday that spanned from a low of $22.59 to a high of $23.28. Yesterday's high of the day pierced the 3-day high of $22.70 on volume of 1.6 ...

Piper Jaffray is upping the price target on Biovail Corporation (NYSE: BVF) to $35 from $30, and maintaining its Overweight rating on strong free cash flow numbers. In the research note to clients ...

By Chip Brian When Biovail (NYSE:BVF) reported earnings 15 days ago on August 05, 2010, analysts, on average, expected the company to report earnings of $0.29 on sales of $213 million. The company ...

By Chip Brian Biovail (NYSE:BVF) traded in a range yesterday that spanned from a low of $22.45 to a high of $22.86. Yesterday, the shares gained 0.71%, which took the trading range above the 3-day ...

Motley Fool - Aug 17, 2010 By Charly Travers and Seth Jayson | More Articles Every biotech company wants to discover the cure for cancer, Alzheimer's, or Wii knee. Every biotech investor hopes to catch the next Genzyme. But ...

Biovail (NYSE:BVF) was downgraded to Hold from Buy, $24.5 target, at TD Newcrest. The stock closed Friday at $22.41 which is 2.94% lower than the price one-week ago of ...

Daily Markets - Aug 16, 2010 Biovail Corporation's (NYSE:BVF) reported earnings of 34 cents per share (excluding special items) for its second quarter 2010 earnings, comfortably surpassed the Zacks Consensus Estimate of 26 ... Zacks Analyst Blog Highlights: Biovail, Valeant Pharma, DeVry, Advance Auto Parts and Halliburton Company - Trading Markets

Valeant Pharmaceuticals International and Biovail Corp. have announced that both companies will hold their respective special meetings of shareholders on September 27, for the purpose of ...

By Jennifer Corbett Dooren, Of DOW JONES NEWSWIRES WASHINGTON -(Dow Jones)- A Food and Drug Administration panel Wednesday backed a proposed epilepsy drug called Potiga developed by Valeant ...

ALISO VIEJO, Calif. and TORONTO, Aug. 11 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals International (NYSE: VRX) and Biovail Corporation (NYSE/TSX: BVF) today announced that both companies ...

By Chip Brian Biovail (NYSE:BVF) traded in a range yesterday that spanned from a low of $22.16 to a high of $23.15. Yesterday, the shares gained 3.03%, which took the trading range above the 3-day ...

The stock market indices started the week off with a positive session and gapped up right at the opening. They then backed off, retested, backed and filled for most of the morning, but by mid-day ...